DIPLOMAT PHARMACY, INC.
DPLO
DPLO was delisted on the 7th of February, 2020.
165 hedge funds and large institutions have $1.03B invested in DIPLOMAT PHARMACY, INC. in 2017 Q3 according to their latest regulatory filings, with 21 funds opening new positions, 77 increasing their positions, 42 reducing their positions, and 28 closing their positions.
228% more call options, than puts
Call options by funds: $2.1M | Put options by funds: $641K
83% more repeat investments, than reductions
Existing positions increased: 77 | Existing positions reduced: 42
45% more capital invested
Capital invested by funds: $706M → $1.03B (+$319M)
6% less funds holding
Funds holding: 175 → 165 (-10)
25% less first-time investments, than exits
New positions opened: 21 | Existing positions closed: 28
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CAM
Cortina Asset Management
Milwaukee,
Wisconsin
|
+$23.1M |
| 2 |
RG
Redmile Group
San Francisco,
California
|
+$16.2M |
| 3 |
BlackRock
New York
|
+$14.2M |
| 4 |
Dimensional Fund Advisors
Austin,
Texas
|
+$9.07M |
| 5 |
MCM
Matarin Capital Management
New York
|
+$8.85M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
FCM
Frontier Capital Management
Boston,
Massachusetts
|
-$27.7M |
| 2 |
Citadel Advisors
Miami,
Florida
|
-$16.9M |
| 3 |
Balyasny Asset Management
Chicago,
Illinois
|
-$10.8M |
| 4 |
Victory Capital Management
San Antonio,
Texas
|
-$6.62M |
| 5 |
HIM
Hermes Investment Management
London Uk,
United Kingdom
|
-$4.44M |
DPLO Hedge Fund Activity: Q3 2017 in Review
165 of the 4,011 institutional investors tracked by Wall St. Rank reported a position in DIPLOMAT PHARMACY, INC. (DPLO) for Q3 2017, worth a combined $1.03B — up 45% from $706M a quarter earlier.
Sellers outnumbered buyers: 28 funds closed out of DPLO and 21 opened new positions — a net loss of 7 holders — while 42 trimmed existing stakes and 77 added.
The largest buyer was Cortina Asset Management, adding an estimated $23.1M. The largest seller was Frontier Capital Management, cutting an estimated $27.7M.
- 165 institutional investors held DIPLOMAT PHARMACY, INC. (DPLO) as of Q3 2017, down from 175 in Q2 2017.
- Funds reported $1.03B of DIPLOMAT PHARMACY, INC. stock for Q3 2017, up 45% quarter-over-quarter.
- 21 funds opened new DIPLOMAT PHARMACY, INC. positions in Q3 2017 and 28 closed out, a net change of -7 holders.
- The largest DIPLOMAT PHARMACY, INC. buyer in Q3 2017 was Cortina Asset Management, an estimated $23.1M added.
- The largest DIPLOMAT PHARMACY, INC. seller in Q3 2017 was Frontier Capital Management, an estimated $27.7M sold.
Based on aggregated 13F filings for Q3 2017.